Indian online pharmacy startup PharmEasy is planning to raise about $300 million in a new round of funding at a 90% markdown from the previous valuation.
Should PharmEasy succeed in securing the new funding, its valuation will drop to half of the total capital it has raised over years.The startup plans to raise new financing through a rights issue that would value the price of its shares at 5 Indian rupees, down from 50 earlier.
# Disclaimer- Please note that S3 Insights has been created with the primary goal of providing its readers with up-to-date information on the Financial Markets. Its purpose is to share knowledge about Financial products, insights from Market experts, recent developments in the financial industry, and business-related information about companies. It is important to emphasize that the S3 Insights should not be interpreted as providing any form of advice. It does not intend to recommend or endorse the buying, selling, or trading of any financial product. S3 Insights is purely educational in nature.